{"transactions":[{"id":3390074,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":154300,"kind":"person","name":"Phillips Matthew V","position":1,"cik":"0001729197","reported_name":"Phillips Matthew V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-10-21T21:15:43.000Z","date":"2019-08-23","kind":"grant","acquired":true,"shares":512500,"price":1.07,"value":548375.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to the Settlement Agreement effective August 23, 2019 by and among MVP Ventures, LLC, Freemantle LLC and LRS International LLC, in exchange for the settlement and termination of Freemantle LLC's and LRS International LLC's certain interests in the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"MVP Ventures LLC (\"MVP\") is the record holder of the securities. The reporting person is the founder and principal of MVP and may be deemed to beneficially own the securities held by MVP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein."}],"balance_after":512500,"source":{"system":"sec-edgar","filing":"0001578563-19-000034","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000034/primary_doc.xml","form_type":"4"}},{"id":3493768,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":154300,"kind":"person","name":"Phillips Matthew V","position":1,"cik":"0001729197","reported_name":"Phillips Matthew V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-06-12T01:04:02.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":523,"price":2.8475,"value":1489.2425,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":1020,"source":{"system":"sec-edgar","filing":"0001578563-19-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000023/primary_doc.xml","form_type":"4"}},{"id":3567586,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":154300,"kind":"person","name":"Phillips Matthew V","position":1,"cik":"0001729197","reported_name":"Phillips Matthew V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T23:36:51.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months."}],"balance_after":145000,"derivative":{"exercise_price":6.22,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001578563-19-000013","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000013/primary_doc.xml","form_type":"4"}},{"id":3735115,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":154300,"kind":"person","name":"Phillips Matthew V","position":1,"cik":"0001729197","reported_name":"Phillips Matthew V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-12-11T22:22:21.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":497,"price":2.8475,"value":1415.2075,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":497,"source":{"system":"sec-edgar","filing":"0001729197-18-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000172919718000003/primary_doc.xml","form_type":"4"}},{"id":4090845,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":154300,"kind":"person","name":"Phillips Matthew V","position":1,"cik":"0001729197","reported_name":"Phillips Matthew V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-24T21:46:09.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant shall vest one-fourth on each of the first, second, third and fourth anniversaries of the date of grant, provided Mr. Phillips is then an officer of the Company."}],"balance_after":100000,"derivative":{"exercise_price":3.21,"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001729197-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000172919718000002/primary_doc.xml","form_type":"4"}}]}